Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy

Fig. 3

The expression levels of TIMM8A in different stages of BRCA, UCEC, and corresponding normal tissues. A Differences of TIMM8A expression levels in BRCA and corresponding normal tissues. B Differences of TIMM8A expression levels in UCEC and corresponding normal tissues. C Differences of TIMM8A expression levels in different BRCA stage. D TIMM8A expression levels of different UCEC stage difference

Back to article page